Hematology Research at Hospital Universitario De Salamanca
Clinical research at Hospital Universitario De Salamanca focuses on Hemic and Lymphatic Diseases, with a strong emphasis on myelodysplastic syndrome in people with IPSS-R low- or intermediate-risk disease. The studies are designed to better understand treatment benefit and safety in a common blood disorder seen in the hematology setting.
- Evaluating a new oral azacitidine approach for myelodysplastic syndrome
- Comparing treatment effectiveness against best supportive care
- Assessing safety, response, and overall clinical value of a potential new therapy
This work aims to improve care for patients with lower-risk myelodysplastic syndrome by identifying more effective and practical treatment options.
